Tag Archives: Cancer Genome

Colorectal Cancer Molecules and Genes Reveal Surprises

A Labor Day salute to the hard-working scientists—doctors, PhDs, lab techs, technology inventors—who have done some  heavy lifting to peer into the tiniest recesses of cells, genes, and molecules to unravel what makes colorectal cancer happen. In the widest and deepest effort to date, the Cancer Genome Atlas Project has produced some surprises and key clues about colorectal cancer, published recently in the journal Nature. It was almost “ industrial-strength genetics to try to unpick and take apart the genetic coding,” according to Dr. David Kerr, professor at the University of Oxford and Past President of the European Society for Medical Oncology.  One of the surprises for colorectal cancer—the third

Leading GI Cancer Researcher Updates Patients

Last night, Dr. Edith Mitchell of Thomas Jefferson University Kimmel Cancer Center in Philadelphia, PA, updated colorectal cancer patients on the latest research and treatment news in an online webinar. Dr. Mitchell highlighted the most important news for colon and rectal cancer patients to come from the 2011 Gastrointestinal Cancers Symposium held in San Francisco last month. She answer such questions as… “Can doctors determine the chances that my cancer may return?” “Can my doctors determine if I need chemotherapy?” “Does Avastin or Erbitux benefit my stage III cancer treatment?” “Are there any promising new treatments on the horizon?”

C3 at AACR 2010

C3 Board Chair Nancy Roach and C3 staffer Kate Murphy and were part of the Scientist-Survivor Program at the American Association for Cancer Research 101st Annual Meeting in Washington this week. Nancy was a mentor for a group of patient advocates who were attending AACR .  For Kate this was a third AACR Annual Meeting.  She presented a poster about C3 and its work. This year’s meeting theme Conquering Cancer Through Discovery Research led to more than 700 presentations and 6,500 posters presenting key basic and translational research.

Top